January 20, 2025 MabPlex Facilitates Commercialization of Teruisi’s TRS005 Program with Successful Execution of PPQ Milestone
November 19, 2019 MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers
